Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Uterine Ablation Effective in Reducing Menstrual Bleeding

Dr. John Thoppil, founder of River Place OB/GYN, Says the Procedure is Not for All Women; Offers Tips.


News provided by

River Place Obstetrics and Gynecology

Aug 21, 2018, 09:00 ET

Share this article

Share toX

Share this article

Share toX

Dr. John Thoppil
Dr. John Thoppil

AUSTIN, Texas, Aug. 21, 2018 /PRNewswire-PRWeb/ -- Uterine ablations are minimally invasive procedures that destroy the lining of the uterus to reduce or stop abnormal menstrual blood flow. They are safe, effective and enhance quality of life, according to the latest scientific findings published June 2018 in Current Obstetrics and Gynecology Reports.

"Researchers have determined that the beneficial effects of this procedure -- endometrial ablation (or EA) can be sustained for years afterwards," says Austin Texas-based obstetrician-gynecologist with River Place OB/GYN, John Thoppil, MD, commenting on this medical report.

If all else fails, contact your gynecologist for a thorough examination to ensure the heavy bleeding is not due to more serious disorders.

Post this

However, he cautions that not every woman with heavy periods is a candidate for EA -- even if other first-option treatments, including medications and intrauterine devices, fail to correct the bleeding problem -- and that undergoing the procedure is no guarantee for preventing a hysterectomy in the future.

More than 500,000 endometrial ablations are performed in the United States annually, says Dr. Thoppil. The procedure, which often can be done in a doctor's office, involves insertion of a thin instrument into the uterus by passing it through the vagina and cervix. Using this tool, the physician can apply various types of energy – radiofrequency, microwaves, hot fluids, heat or extreme cold – to ablate the uterine lining (endometrium), thereby lessening the amount of blood lost during menstruation.

"Menorrhagia, or heavy menstrual blood flow, is a serious, but treatable medical problem, affecting quality of life for thousands of women. Unfortunately, more than half of those who suffer from it never see a physician. Many of them presume the condition is just part of the normal course of aging," states Dr. Thoppil.

Among pre-menopausal women who do visit a gynecologist, 20 percent to 30 percent seek help for menstrual bleeding, adds Dr. Thoppil.

"Abnormally heavy periods, those lasting more than seven or eight days, are a frequent reason why women miss work and social events" Dr. Thoppil indicates. "If left untreated, the blood loss can lead to anemia,"

Not all women are good candidates for this technique. She must generally have a normal size uterine cavity without signs of pre-cancer (hyperplasia) or cancer, Dr. Thoppil says.

"The procedure also should not be performed on women who are past menopause or on patients of child-bearing age who may still want to become pregnant," he says. While EA is not a sterilization process it can make pregnancy difficult – and dangerous, greatly increasing a woman's risk for complications like miscarriage and ectopic (tubal) pregnancies.

Meanwhile, in a 2017 discussion published in Case Reports in Women's Health, experts say that about 25 percent of women who undergo endometrial ablation require a hysterectomy within five years following the procedure but indicate this failure rate could be reduced with improved patient selection.

Dr. Thoppil concurs. "EA is not new, however, there remains a surprising lack of comparative, clinical data about the long-term effectiveness of the various EA techniques and tools," he says. "For that reason, physicians must take special care to understand each patient's specific needs and condition, conduct a thorough examination, select the most appropriate device for performing the procedure, and develop the necessary protocols for close monitoring of patients following ablation," he adds.

Dr. Thoppil emphasizes that EA is extremely effective in well selected patients, with roughly 90% patient satisfaction. In fact, 50% of patients don't have menses at all.

"If all else fails, contact your gynecologist for a thorough examination to ensure the heavy bleeding is not due to more serious disorders. The doctor may initially prescribe progesterone tablets, oral contraceptives or insertion of a hormonal intrauterine device. If done with child bearing an ablation may be the best choice," Dr. Thoppil says.

John Thoppil, MD, leads River Place Obstetrics and Gynecology, based in Austin, Texas. A board-certified obstetrician-gynecologist and a Fellow of the American College of Obstetricians and Gynecologists, Dr. Thoppil also is an assistant professor at Texas A&M University College of Medicine. He earned his MD at Baylor College of Medicine and completed residency training at Wilford Hall Medical Center, Lackland Air Force Base. http://www.riverplaceobg.com

SOURCE River Place Obstetrics and Gynecology

Related Links

http://www.riverplaceobg.com

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.